Patent ID: 9149517
Filing Date: 2015-10-06
Classification: A61K,A61P,C07K,C12N

Abstract:
1. An isolated polypeptide composition comprising a fusion of residues from at least three homologous human papillomavirus L2 immunogenic peptides from at least three isolates of human papilloma virus wherein a first immunogenic peptide is coupled to a second homologous immunogenic peptide from a second isolate of human papilloma virus and the second immunogenic homologous peptide is coupled to a third homologous immunogenic peptide from a third isolate of human papilloma virus and wherein the immunogenic peptides are selected from one or more of: L2 residues 11-200 from HPV6, HPV16 and HPV18; or L2 residues 11-88 from HPV1, HPV5, HPV6, HPV16, HPV18; or L2 residues 17-36 from HPV1, HPV2, HPV5, HPV6, HPV8, HPV11, L2 residues 11-88 from HPV6, HPV16, HPV18, HPV31, HPV39, HPV51, HPV56 and HPV73.